Patent & IP news for April 18, 2014

New Patent Litigations

USPTO Weekly Stats


Recent Patent & IP Blogs

Judge Koh's boss finds Rockstar's scare tactics advance Apple's interests against Android from

In the ongoing Apple v. Samsung II trial in the Northern District of California, Apple's lawyers try hard to downplay Google's role, though it's blindingly obvious that Google is the true target ...

Share via E–mail | Twitter | Facebook

AIA Trial Roundtables -- PTAB Takes Its Show on the Road from

By Andrew Williams -- This week, the Patent Trial and Appeal Board began hosting a month-long series of roundtables devoted to sharing information about the new AIA trials. These include inter partes reviews, covered business method ...

Share via E–mail | Twitter | Facebook

Apple's counsel stresses USPTO's independence -- but the USPTO doubts the autocomplete patent from

The Apple v. Samsung II trial continues today with Samsung's challenges to Apple's asserted patents. In this context, Apple's counsel attacked the credibility of a Samsung expert witness, as journalists including MLex ...

Share via E–mail | Twitter | Facebook

post image 3D printing: be careful what you wish for? from

This blog post will be about taxes. In particular, we will consider whether the utopian vision of "every home a workplace" thanks to 3D printing also contains a dystopian element from the perspective of the ...

Share via E–mail | Twitter | Facebook

ALJ Gildea Sets Procedural Schedule In Certain Lithium Silicate Materials (337-TA-911) from

On April 15, 2014, ALJ E. James Gildea issued Order No. 4 in Certain Lithium Silicate Materials and Products Containing the Same (Inv. No. 337-TA-911). By way of background, the investigation is based on a ...

Share via E–mail | Twitter | Facebook

Sale of Infringing Heart Valves Preliminarily Enjoined Subject to Carve-Out for “Patients Who Cannot be Helped” by Plaintiff’s Devices from

Following a jury verdict of willful infringement, the court granted plaintiffs' motion for a preliminary injunction to preclude defendant from selling its heart valves, subject to certain conditions to address the public interest. "The expert ...

Share via E–mail | Twitter | Facebook

post image Guest Post by Prof. Sichelman: Stop Bashing Academics: Why Mark Lemley, Peter Menell, and Rob Merges are Highly Qualified to Teach and Write about Patent Law from

Guest Post by Prof. Ted Sichelman, University of San Diego, School of Law Recently, Hal Wegner has been circulating and commenting upon the qualifications of patent law professors. For example, he lists whether patent law ...

Share via E–mail | Twitter | Facebook

MPEP Ninth Edition from

The US Patent and Trademark Office released the ninth edition of the MPEP in March.  A summary by the PTO of the changes is available here: [Summary].  The searchable version of the MPEP is available ...

Share via E–mail | Twitter | Facebook

MIT Technology Review on CRISPR patent, US 8,697,359 inventor Feng Zhang from

In a post titled The Harvard-MIT genomic science institute trumpets its claims to an important genome editing technology , the MIT Tech Review talked glowingly about US Patent 8,697,359.

Application 14/054,414 was ...

Share via E–mail | Twitter | Facebook

They Invented What? (No. 239) from

U.S. Patent No. 4,151,613: Protective device for the buttocks and hips of a person for use in skateboarding. JW Note:  For all our readers who are also skateboarding enthusiasts! What is claimed ...

Share via E–mail | Twitter | Facebook

MVS Filewrapper® Blog: USPTO Issues New Examination Guidelines for Patent Subject Matter Eligibility from

The basic requirements for filing a U.S. utility patent are rather straightforward. Patents are granted for new, useful and non-obvious processes, products or compositions of matter. Similarly, any new, useful and non-obvious improvement to ...

Share via E–mail | Twitter | Facebook

Takeda Part Two: Destroy Evidence, Pay the Price — Eli Lily and Takeda Pharmaceutical Co. Get Hit For $9 Billion Punitive Damages Verdict from

Recently, in In re Actos (Pioglitazone) Products Liability Litigation, MDL No. 11-2299, a Louisiana federal jury awarded $9 billion in punitive damages against Takeda Pharmaceutical Co. (“Takeda”) and Eli Lily & Co. (“Lily”). The verdict was ...

Share via E–mail | Twitter | Facebook

20 Years Of TRIPS: Max Planck Launches Declaration On Patent Protection from

The Max Planck Institute for Innovation and Competition has launched a Declaration on Patent Protection with the aim to “clarify some of the regulatory options states still retain under international law, in particular the TRIPS ...

Share via E–mail | Twitter | Facebook

post image Apple Seeks $2.2 Billion in Damages from Samsung from

The 2nd trial between Apple and Samsung is 5 days in, Apple is seeking $2.2 billion in damages from Samsung for alleged infringements of 5 of Apple’s patents. Apple filed Apple Inc. v ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of service
Privacy policy
For DMCA requests contact